Karen Krumeich - Soligenix CFO, Senior Vice President
| SNGX Stock | USD 0.40 0.01 2.44% |
President
Ms. Karen R. Krumeich was appointed as Chief Financial Officer, Senior Vice President and Corporationrationrate Secretary of the Company., effective June 30, 2016. was with our company since June 2016 and is currently our Senior Vice President and Chief Financial Officer. She has served as Chief Financial Officer and Vice President of Finance for public and private emerginggrowth, startup and national companies in various sectors of healthcare, including pharmaceuticals, medical devices and healthcare service companies. She has expertise in equity financings, both private and public, SarbanesOxley compliance, acquisitions and integrations, strategic business development and operations analysis. Most recently Ms. Krumeich was the Vice President of Finance for Cerecor Inc., a clinical stage neuroscience company. At Cerecor she was involved in the companys equity financings and was responsible for all finance and administrative functions. Prior to joining Cerecor she was a CFO Partner with Tatum, LLC, a national consulting firm, and a member of the firms National Healthcare Group. As a Partner with Tatum, she served as Interim Chief Financial Officer for drug development and medical device companies. Prior to joining Tatum in 2006, she was the Vice President of Finance and Chief Financial Officer of Strata Skin Sciences, Inc., a publicly traded developmentstage medical device company. At Mela Sciences, she played a key role in the companys initial public offering and was responsible for all functional areas of finance and accounting, administration, and investor relations. As Vice President of Finance of Gran Care Pharmacy, Inc., she was responsible for the financial leadership of the pharmacy division and directed an aggressive acquisition program since 2016.
| Age | 62 |
| Tenure | 8 years |
| Professional Marks | CPA |
| Address | 29 Emmons Drive, Princeton, NJ, United States, 08540 |
| Phone | 609 538 8200 |
| Web | https://www.soligenix.com |
Soligenix Management Efficiency
The company has return on total asset (ROA) of (0.3997) % which means that it has lost $0.3997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (237.8376) %, meaning that it created substantial loss on money invested by shareholders. Soligenix's management efficiency ratios could be used to measure how well Soligenix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.66 in 2024. Return On Capital Employed is likely to rise to -2.22 in 2024. At this time, Soligenix's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 909.3 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 275.5 K in 2024.Similar Executives
| Found 8 records | PRESIDENT Age | ||
| Mary Templeton | Windtree Therapeutics | 67 | |
| Srinivas Subramanian | Avenue Therapeutics | 53 | |
| Michael Magee | Windtree Therapeutics | 53 | |
| William Roberts | Windtree Therapeutics | 44 | |
| Kathryn Cole | Windtree Therapeutics | 48 | |
| Steven Simonson | Windtree Therapeutics | 65 | |
| John Tattory | Windtree Therapeutics | 58 | |
| Robert Lisicki | Zura Bio Limited | 56 | |
Management Performance
| Return On Equity | -237.84 | ||||
| Return On Asset | -0.4 |
Soligenix Leadership Team
Elected by the shareholders, the Soligenix's board of directors comprises two types of representatives: Soligenix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Soligenix. The board's role is to monitor Soligenix's management team and ensure that shareholders' interests are well served. Soligenix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Soligenix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jerome Zeldis, Independent Director | ||
| Richard Straube, Senior Vice President and Chief Medical Officer | ||
| Marco Brughera, Director | ||
| Gregg Lapointe, Independent Director | ||
| Keith Brownlie, Independent Director | ||
| Karen Krumeich, CFO, Senior Vice President | ||
| Richard Dunning, Ex Officer | ||
| Anthony Lapointe, Independent Director | ||
| Diane Parks, Director | ||
| Oreola Donini, Chief Scientific Officer and Sr. VP | ||
| Christopher Schaber, Chairman, CEO and Pres | ||
| Joseph Warusz, Acting CFO, Vice President - Finance, Corporate Secretary | ||
| Mark Pearson, Director | ||
| Robert Rubin, Independent Director | ||
| CGMA CPA, CFO VP | ||
| MSc MD, Senior Officer |
Soligenix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Soligenix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -237.84 | ||||
| Return On Asset | -0.4 | ||||
| Operating Margin | (8.73) % | ||||
| Current Valuation | (680.78 K) | ||||
| Shares Outstanding | 14.24 M | ||||
| Shares Owned By Insiders | 0.07 % | ||||
| Shares Owned By Institutions | 2.70 % | ||||
| Number Of Shares Shorted | 115.8 K | ||||
| Price To Earning | (1.67) X | ||||
| Price To Book | 1.61 X |
Currently Active Assets on Macroaxis
When determining whether Soligenix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soligenix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soligenix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soligenix Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soligenix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Soligenix Stock please use our How to Invest in Soligenix guide.Note that the Soligenix information on this page should be used as a complementary analysis to other Soligenix's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Soligenix Stock analysis
When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Soligenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soligenix. If investors know Soligenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soligenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.79) | Revenue Per Share 0.108 | Quarterly Revenue Growth (0.33) | Return On Assets (0.40) | Return On Equity (237.84) |
The market value of Soligenix is measured differently than its book value, which is the value of Soligenix that is recorded on the company's balance sheet. Investors also form their own opinion of Soligenix's value that differs from its market value or its book value, called intrinsic value, which is Soligenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soligenix's market value can be influenced by many factors that don't directly affect Soligenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soligenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Soligenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soligenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.